• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

心脏再同步治疗(CRT)后心脏交感神经活动改善的“可逆性”扩张型心肌病的长期随访:“CRT 超反应者”是否患有“不同步性心肌病”?

Long-term follow-up of "reversible" dilated cardiomyopathy with improvement of cardiac sympathetic nerve activity after cardiac resynchronization therapy (CRT): Do "CRT superresponders" have "dyssynchrony-induced cardiomyopathy"?

作者信息

Ishibashi Kazuya, Osamura Tomoko, Shiraishi Hirokazu, Shirayama Takeshi, Yamahara Yasuhiro, Matsubara Hiroaki

机构信息

Department of Cardiology, Saiseikai Kyoto Hospital, Kyoto, Japan.

Department of Cardiovascular Medicine, Kyoto Prefectural University School of Medicine, Kyoto, Japan.

出版信息

J Cardiol Cases. 2009 Nov 8;1(1):e56-e62. doi: 10.1016/j.jccase.2009.07.004. eCollection 2010 Feb.

DOI:10.1016/j.jccase.2009.07.004
PMID:30615771
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6264965/
Abstract

We report a case of idiopathic dilated cardiomyopathy with severe heart failure and complete left bundle branch block (CLBBB) which exhibited an excellent response to cardiac resynchronization therapy (CRT). A 71-year-old male had been treated for 9 years with medication for chronic heart failure. He was referred to hospital with a complaint of dyspnea. An electrocardiogram showed CLBBB, with a QRS-width of 200 ms. Markedly dilated left ventricular (LV) chamber with a low ejection fraction (EF) of 18% and severe mitral regurgitation were registered by echocardiogram. Myocardial neuronal I-metaiodobenzylguanidine uptake was reduced, with a heart-to-mediastinum (H/M) ratio of 1.88. Immediately after the introduction of CRT, clinical improvement was observed. At 1-year follow-up, LV chamber size and cardiac function were almost normalized, with an EF of 53%. Cardiac sympathetic nerve activity (CSNA) was simultaneously normalized, with an H/M ratio of 2.32 and a washout rate of 14.7%. However, after the cessation of carvedilol administration, CSNA and LV systolic function were slightly aggravated, with an H/M ratio of 2.20, a washout rate of 15.9%, and an EF of 44%. In the present case, the excellent improvement in cardiac function and CSNA was caused by the combined effects of beta-blocker therapy and CRT.

摘要

我们报告一例患有严重心力衰竭和完全性左束支传导阻滞(CLBBB)的特发性扩张型心肌病患者,该患者对心脏再同步治疗(CRT)表现出极佳的反应。一名71岁男性因慢性心力衰竭接受药物治疗已9年。他因呼吸困难前来就诊。心电图显示CLBBB,QRS波宽度为200毫秒。超声心动图显示左心室(LV)腔明显扩张,射血分数(EF)低至18%,并伴有严重二尖瓣反流。心肌神经元I-间碘苄胍摄取减少,心/纵隔(H/M)比值为1.88。在引入CRT后立即观察到临床改善。在1年的随访中,左心室腔大小和心脏功能几乎恢复正常,EF为53%。心脏交感神经活动(CSNA)同时恢复正常,H/M比值为2.32,洗脱率为14.7%。然而,在停用卡维地洛后,CSNA和左心室收缩功能略有加重,H/M比值为2.20,洗脱率为15.9%,EF为44%。在本病例中,心脏功能和CSNA的极佳改善是由β受体阻滞剂治疗和CRT的联合作用所致。

相似文献

1
Long-term follow-up of "reversible" dilated cardiomyopathy with improvement of cardiac sympathetic nerve activity after cardiac resynchronization therapy (CRT): Do "CRT superresponders" have "dyssynchrony-induced cardiomyopathy"?心脏再同步治疗(CRT)后心脏交感神经活动改善的“可逆性”扩张型心肌病的长期随访:“CRT 超反应者”是否患有“不同步性心肌病”?
J Cardiol Cases. 2009 Nov 8;1(1):e56-e62. doi: 10.1016/j.jccase.2009.07.004. eCollection 2010 Feb.
2
Left ventricular dyssynchrony predicts right ventricular remodeling after cardiac resynchronization therapy.左心室不同步可预测心脏再同步治疗后右心室重构。
J Am Coll Cardiol. 2005 Dec 20;46(12):2264-9. doi: 10.1016/j.jacc.2005.04.069.
3
Comparison of benefits from cardiac resynchronization therapy in patients with ischemic cardiomyopathy versus idiopathic dilated cardiomyopathy.缺血性心肌病患者与特发性扩张型心肌病患者接受心脏再同步治疗的获益比较。
Am J Cardiol. 2004 Apr 1;93(7):860-3. doi: 10.1016/j.amjcard.2003.12.024.
4
Left ventricular resynchronization is mandatory for response to cardiac resynchronization therapy: analysis in patients with echocardiographic evidence of left ventricular dyssynchrony at baseline.左心室再同步化是心脏再同步治疗产生反应的必要条件:对基线时有左心室不同步超声心动图证据患者的分析
Circulation. 2007 Sep 25;116(13):1440-8. doi: 10.1161/CIRCULATIONAHA.106.677005. Epub 2007 Sep 4.
5
Evaluation of left bundle branch block as a reversible cause of non-ischaemic dilated cardiomyopathy with severe heart failure. A new concept of left ventricular dyssynchrony-induced cardiomyopathy.评估左束支传导阻滞作为严重心力衰竭的非缺血性扩张型心肌病的可逆病因。左心室不同步性心肌病的新概念。
Europace. 2005 Nov;7(6):604-10. doi: 10.1016/j.eupc.2005.06.005. Epub 2005 Sep 13.
6
The effects of cardiac resynchronization therapy on left ventricular and mitral valve geometry and secondary mitral regurgitation in patients with left bundle branch block.心脏再同步治疗对左束支传导阻滞患者左心室及二尖瓣形态和继发性二尖瓣反流的影响。
Echocardiography. 2019 Aug;36(8):1450-1458. doi: 10.1111/echo.14444. Epub 2019 Aug 19.
7
Cardiac resynchronization therapy restored ventricular septal myocardial perfusion and enhanced ventricular remodeling in patients with nonischemic cardiomyopathy presenting with left bundle branch block.心脏再同步治疗可恢复非缺血性心肌病伴左束支传导阻滞患者的室间隔心肌灌注,并增强心室重构。
Heart Rhythm. 2014 May;11(5):836-41. doi: 10.1016/j.hrthm.2014.02.014. Epub 2014 Feb 19.
8
Clinical usefulness of gated technetium-99m sestamibi myocardial perfusion single-photon emission computed tomography with phase analysis for the management of patients with isolated ventricular noncompaction.门控锝-99m 甲氧基异丁基异腈心肌灌注单光子发射计算机断层扫描结合相位分析在孤立性心室肌致密化不全患者管理中的临床应用价值
J Cardiol Cases. 2014 Dec 24;11(4):101-104. doi: 10.1016/j.jccase.2014.11.006. eCollection 2015 Apr.
9
Effects of cardiac resynchronization therapy on left ventricular remodeling and dyssynchrony in patients with left ventricular noncompaction and heart failure.心脏再同步治疗对左心室心肌致密化不全合并心力衰竭患者左心室重构及不同步性的影响
Int J Cardiovasc Imaging. 2015 Feb;31(2):329-37. doi: 10.1007/s10554-014-0568-8. Epub 2014 Nov 13.
10
Cardiac Resynchronization Therapy Defibrillator Treatment in a Child with Heart Failure and Ventricular Arrhythmia.心脏再同步化治疗除颤器用于一名心力衰竭合并室性心律失常儿童的治疗
Korean J Thorac Cardiovasc Surg. 2016 Aug;49(4):292-4. doi: 10.5090/kjtcs.2016.49.4.292. Epub 2016 Aug 5.

本文引用的文献

1
Normalization of left ventricular function following cardiac resynchronization therapy: left bundle branch block as a potential etiology of dilated cardiomyopathy.心脏再同步治疗后左心室功能的正常化:左束支传导阻滞作为扩张型心肌病的潜在病因
Circ J. 2008 Jun;72(6):1030-3. doi: 10.1253/circj.72.1030.
2
Prognostic value of myocardial 123I-metaiodobenzylguanidine (MIBG) parameters in patients with heart failure: a systematic review.心力衰竭患者心肌123I-间碘苄胍(MIBG)参数的预后价值:一项系统评价
Eur Heart J. 2008 May;29(9):1147-59. doi: 10.1093/eurheartj/ehn113. Epub 2008 Mar 17.
3
Improvement in cardiac sympathetic nerve activity in responders to resynchronization therapy.
Europace. 2008 Mar;10(3):374-8. doi: 10.1093/europace/eun017.
4
Cardiac resynchronization therapy: "nonresponders" and "hyperresponders".心脏再同步治疗:“无反应者”与“高反应者”
Heart Rhythm. 2008 Feb;5(2):193-7. doi: 10.1016/j.hrthm.2007.09.023. Epub 2007 Oct 2.
5
Cardiac sympathetic activity pre and post resynchronization therapy evaluated by 123I-MIBG myocardial scintigraphy.通过¹²³I-间碘苄胍心肌闪烁显像评估心脏再同步治疗前后的心脏交感神经活动。
J Nucl Cardiol. 2007 Nov-Dec;14(6):852-9. doi: 10.1016/j.nuclcard.2007.08.004. Epub 2007 Oct 18.
6
Evaluation of cardiac sympathetic nerve activity and left ventricular remodelling in patients with dilated cardiomyopathy on the treatment containing carvedilol.对接受含卡维地洛治疗的扩张型心肌病患者心脏交感神经活动及左心室重构的评估。
Eur Heart J. 2007 Apr;28(8):989-95. doi: 10.1093/eurheartj/ehm048. Epub 2007 Apr 4.
7
Beta-blocker therapy induces ventricular resynchronization in dilated cardiomyopathy with narrow QRS complex.β受体阻滞剂治疗可使QRS波群狭窄的扩张型心肌病患者实现心室再同步化。
J Am Coll Cardiol. 2007 Feb 20;49(7):778-83. doi: 10.1016/j.jacc.2006.05.081. Epub 2007 Feb 5.
8
Evaluation of left bundle branch block as a reversible cause of non-ischaemic dilated cardiomyopathy with severe heart failure. A new concept of left ventricular dyssynchrony-induced cardiomyopathy.评估左束支传导阻滞作为严重心力衰竭的非缺血性扩张型心肌病的可逆病因。左心室不同步性心肌病的新概念。
Europace. 2005 Nov;7(6):604-10. doi: 10.1016/j.eupc.2005.06.005. Epub 2005 Sep 13.
9
Understanding nonresponders of cardiac resynchronization therapy--current and future perspectives.了解心脏再同步治疗无反应者——现状与未来展望
J Cardiovasc Electrophysiol. 2005 Oct;16(10):1117-24. doi: 10.1111/j.1540-8167.2005.40829.x.
10
Carvedilol improves left ventricular function in heart failure patients with idiopathic dilated cardiomyopathy and a wide range of sympathetic nervous system function as measured by iodine 123 metaiodobenzylguanidine.卡维地洛可改善特发性扩张型心肌病所致心力衰竭患者的左心室功能,且这些患者具有广泛的交感神经系统功能,这一功能通过碘123间碘苄胍进行测定。
J Nucl Cardiol. 2002 Nov-Dec;9(6):608-15. doi: 10.1067/mnc.2002.127717.